Ligne de temps

Jérémy Brunet
Technicien(ne)
02 avr. 2024
publication

A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model.

Lire plus
01 janv. 2022
publication

Safety and immunogenicity of a measles-vectored SARS-CoV-2 vaccine candidate, V591 / TMV-083, in healthy adults: results of a randomized, placebo-controlled Phase I study.

Lire plus
02 oct. 2015
news

iGEM Pasteur Team ranked in the Bronze Medal category at the Giant Jamboree in Boston

Lire plus